Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -1060.3% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 16.9 | n/a |
Pr/Book | 1.6 |
Latest | F'cast | |
---|---|---|
Revenue | 810.9% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Jun-20 | 1.06 | (20.38) | (54.48)p | n/a | n/a | n/a | n/a | 0.0% |
30-Jun-21 | 0.69 | (1.85) | (1.19)p | n/a | n/a | n/a | n/a | 0.0% |
30-Jun-22 | 0.05 | (5.63) | 5.50p | 3.2 | n/a | n/a | n/a | 0.0% |
30-Jun-23 | 0.06 | (5.98) | (5.50)p | n/a | n/a | n/a | n/a | 0.0% |
30-Jun-24 | 0.50 | (7.75) | (4.70)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
CYP2C19-ID Kit used to support expansion | 13-May-2025 | 07:00 | RNS |
CYP2C19 ID Kit CE-IVD certification update | 02-May-2025 | 13:30 | RNS |
Additional grant funding under DEVOTE programme | 02-Apr-2025 | 07:01 | RNS |
Genedrive upbeat on publication of clinical perf... | 27-Dec-2024 | ShareCast |
Genedrive full-year revenue rises | 29-Nov-2024 | ShareCast |
Director dealings: Genedrive chairman snaps up s... | 15-Aug-2024 | ShareCast |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 1.36p |
Change Today | -0.010p |
% Change | -0.73 % |
52 Week High | 4.53 |
52 Week Low | 1.35 |
Volume | 15,778,949 |
Shares Issued | 624.90m |
Market Cap | £8.47m |
Beta | 0.03 |
RiskGrade | 747 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
17:06 | 4,314 @ 1.36p |
16:27 | 2,256 @ 1.35p |
16:26 | 496 @ 1.35p |
16:23 | 71,614 @ 1.36p |
16:22 | 10,000 @ 1.36p |
You are here: research